Can $Moderna, Inc.(MRNA)$ conq

Can $Moderna, Inc.(MRNA)$ conquer cancer with AI and mRNA?

The first Phase 3 win for a personalized mRNA cancer vaccine is in. Intismeran plus $Merck(MRK)$ Keytruda beat Keytruda alone on melanoma recurrence and spread, with up to 34 neoantigens per patient.

Then there was the $2.6B zero-coupon convertible, upsized, with hedges to cap dilution. Argus moved to Buy with a $180 target. The XFG booster was cleared by the FDA and MHRA.

COVID paid for the factory. Cancer is the bid.

$Moderna, Inc.(MRNA)$ $Merck(MRK)$

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":602772611618304,"tweetId":"602772611618304","gmtCreate":1788155916000,"gmtModify":1788248562373,"author":{"id":10000000000011394,"idStr":"10000000000011394","authorId":10000000000011394,"authorIdStr":"10000000000011394","name":"Joanne Elinor","avatar":"https://static.tigerbbs.com/6f7166a326215342170a47ea96e7e877","vip":8,"userType":8,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body>Can <a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a> conquer cancer with AI and mRNA?\nThe first Phase 3 win for a personalized mRNA cancer vaccine is in. Intismeran plus <a href=\"https://ttm.financial/S/MRK\">$Merck(MRK)$&nbsp;</a> Keytruda beat Keytruda alone on melanoma recurrence and spread, with up to 34 neoantigens per patient.\nThen there was the $2.6B zero-coupon convertible, upsized, with hedges to cap dilution. Argus moved to Buy with a $180 target. The XFG booster was cleared by the FDA and MHRA.\nCOVID paid for the factory. Cancer is the bid.\n<a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a> <a href=\"https://ttm.financial/S/MRK\">$Merck(MRK)$&nbsp;</a></body></html>","htmlText":"<html><head></head><body>Can <a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a> conquer cancer with AI and mRNA?\nThe first Phase 3 win for a personalized mRNA cancer vaccine is in. Intismeran plus <a href=\"https://ttm.financial/S/MRK\">$Merck(MRK)$&nbsp;</a> Keytruda beat Keytruda alone on melanoma recurrence and spread, with up to 34 neoantigens per patient.\nThen there was the $2.6B zero-coupon convertible, upsized, with hedges to cap dilution. Argus moved to Buy with a $180 target. The XFG booster was cleared by the FDA and MHRA.\nCOVID paid for the factory. Cancer is the bid.\n<a href=\"https://ttm.financial/S/MRNA\">$Moderna, Inc.(MRNA)$&nbsp;</a> <a href=\"https://ttm.financial/S/MRK\">$Merck(MRK)$&nbsp;</a></body></html>","text":"Can $Moderna, Inc.(MRNA)$ conquer cancer with AI and mRNA? The first Phase 3 win for a personalized mRNA cancer vaccine is in. Intismeran plus $Merck(MRK)$ Keytruda beat Keytruda alone on melanoma recurrence and spread, with up to 34 neoantigens per patient. Then there was the $2.6B zero-coupon convertible, upsized, with hedges to cap dilution. Argus moved to Buy with a $180 target. The XFG booster was cleared by the FDA and MHRA. COVID paid for the factory. Cancer is the bid. $Moderna, Inc.(MRNA)$ $Merck(MRK)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/602772611618304","repostId":0,"isVote":1,"tweetType":1,"viewCount":201,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["MRK","MRNA"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":433,"optionInvolvedFlag":false,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/602772611618304"}